12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Company News  |  Deals

Bayer deal

Bayer acquired the 4% of its Schering Pharma subsidiary it did not already own for €98.98...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >